Dafinace 5mg

Haloperidol 5mg

Pregnancy & Lactation
Pregnancy category: C; neonates exposed to antipsychotic drugs during 3rd trimester of pregnancy are at risk for extrapyramidal or withdrawal symptoms after delivery; these complications vary in severity, in some cases being self-limited and in other cases necessitating ICU support and prolonged hospitalization
Lactation: Drug enters breast milk; not recommended

Pregnancy Categories
A: Generally acceptable. Controlled studies in pregnant women show no evidence of fetal risk.

B: May be acceptable. Either animal studies show no risk but human studies not available or animal studies showed minor risks and human studies done and showed no risk.

C: Use with caution if benefits outweigh risks. Animal studies show risk and human studies not available or neither animal nor human studies done.

D: Use in LIFE-THREATENING emergencies when no safer drug available. Positive evidence of human fetal risk.

X: Do not use in pregnancy. Risks involved outweigh potential benefits. Safer alternatives exist.

NA: Information not available.

Remember, keep this and all other medicines out of the reach of children, never share your medicines with others, and use Dafinace 5mg only for the indication prescribed.